Liraglutide 18mg/pen, box of 3 pens (Saxenda/Novo Nordisk)

Liraglutide (Saxenda) injectable prescription medicine for treatment of obesity (BMI >27) and diabetes. Liraglutide (Saxenda) suppresses appetite and delays gastric emptying, promoting a sense of fullness. This results in reduced caloric intake and weight loss. In clinical studies, obese subjects treated with Liraglutide (Saxenda) lost ~5-15% of their body weight over 56 weeks.

(This is a prescription medication which should be used under the supervision of a medical professional)